Pure Biologics S.A.

Equities

PUR

PLPRBLG00010

Biotechnology & Medical Research

Delayed Warsaw S.E. Other stock markets 06:27:28 15/05/2024 pm IST			5-day change	1st Jan Change
7.58 ^PLN	+2.29%		+3.84%	-40.03%

2023	Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Dom Maklerski Navigator S.A. and IPOPEMA Securities S.A. agreed to acquire an unknown minority stake in Pure Biologics Spólka Akcyjna.

December 13, 2022

Dom Maklerski Navigator S.A. and IPOPEMA Securities S.A. agreed to acquire an unknown minority stake in Pure Biologics Spólka Akcyjna on December 13, 2022. GESSEL acted as legal advisor Pure Biologics Spólka Akcyjna

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	PURE BIOLOGICS S.A.	7.58 PLN	+2.29%	+3.84%	62.45L
	IPOPEMA SECURITIES S.A.	3.72 PLN	-1.59%	-2.62%	2.87Cr

Latest news about Pure Biologics S.A.

Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Presage Announces Collaboration with Pure Biologics to Investigate Oncology Agents in Early Development with CIVO® Technology	06/23/06	CI
Dom Maklerski Navigator S.A. and IPOPEMA Securities S.A. agreed to acquire an unknown minority stake in Pure Biologics Spólka Akcyjna.	13/22/13	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2022	16/22/16	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2021	31/22/31	CI
Pure Biologics Sp?lka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15	CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2021	10/21/10	CI
Pure Biologics Spólka Akcyjna announced that it has received €6.7 million in funding from National Centre for Research and Development	21/19/21	CI
Pure Biologics Spólka Akcyjna announced that it has received PLN 10.1 million in funding	24/19/24	CI

Chart Pure Biologics S.A.

Duration

Period

More charts

Company Profile

Pure Biologics SA is a manufacturer of biological products. The Company was founded in August 2010 and is located in Wroclaw, Poland.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
PURE BIOLOGICS S.A.	-40.03%	62.45L
MODERNA, INC.	+29.03%	4.92TCr
IQVIA HOLDINGS INC.	-0.10%	4.21TCr
LONZA GROUP AG	+50.07%	4.04TCr
CELLTRION, INC.	-5.26%	2.89TCr
ICON PUBLIC LIMITED COMPANY	+11.48%	2.61TCr
ALNYLAM PHARMACEUTICALS, INC.	-22.74%	1.87TCr
BIO-TECHNE CORPORATION	+9.06%	1.33TCr
MEDPACE HOLDINGS, INC.	+30.01%	1.23TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.51%	1.2TCr

Other Biotechnology & Medical Research